Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076723
Company: NOSTRUM LABS INC

• Other Important Information from FDA

• REMS

Products on ANDA 076723

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
HYDROMORPHONE HYDROCHLORIDE	HYDROMORPHONE HYDROCHLORIDE	8MG	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 076723

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/18/2005	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/15/2020	SUPPL-11	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
04/15/2020	SUPPL-10	Labeling-Medication Guide, Labeling-Patient Package Insert		Label is not available on this site.
04/15/2020	SUPPL-9	Labeling-Medication Guide, Labeling-Package Insert		Label is not available on this site.
09/18/2018	SUPPL-8	REMS - PROPOSAL - D-N-A		Label is not available on this site.
04/15/2020	SUPPL-6	Labeling-Medication Guide, Labeling-Package Insert		Label is not available on this site.